However, Ho Lam Chan et al. showed that RNF2 is overexpressed in breast cancer and that it functionally associates with ERα and its pioneer factor FOXA1 in ER+ breast cancer cells by promoting the expression of oncogenes and/or regulating chromatin accessibility [32]. The gene discussed is FOXA1; the disease is breast carcinoma.